TGF-β Signaling Pathways in the Development of Diabetic Retinopathy
Abstract
:1. Introduction
2. An Overview of TGF-β Signaling Pathways
3. Association of TGF-β Signaling Pathways in DR
4. Association of BMP Signaling Pathways with DR
5. Association of TGF-β with Immune Cells in DR
6. The Role of TGF-β in DR-Related Neurodegeneration
7. Other Association of TGF-β Superfamily Signaling Pathway in DR
8. Other Molecular Mechanisms Implicated in DR Pathogenesis
9. Current Research on TGF-β’s Potential Role in DR Treatment
10. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Teo, Z.L.; Tham, Y.C.; Yu, M.; Chee, M.L.; Rim, T.H.; Cheung, N.; Bikbov, M.M.; Wang, Y.X.; Tang, Y.; Lu, Y.; et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic review and meta-analysis. Ophthalmology 2021, 128, 1580–1591. [Google Scholar] [CrossRef] [PubMed]
- Aryan, N.; Betts-Obregon, B.S.; Perry, G.; Tsin, A.T. Oxidative Stress Induces Senescence in Cultured RPE Cells. Open Neurol. J. 2016, 10, 83–87. [Google Scholar] [CrossRef] [PubMed]
- Khan, R.; Yee Ooi, X.; Parvus, M.; Valdez, L.; Tsin, A. Advanced Glycation End Products: Formation, Role in Diabetic Complications, and Potential in Clinical Applications. In The Eye and Foot in Diabetes; Grigsby, J., Derbel, F., Eds.; IntechOpen: Rijeka, Croatia, 2020; Available online: https://www.intechopen.com/books/the-eye-and-foot-in-diabetes/advanced-glycation-end-products-formation-role-in-diabetic-complications-and-potential-in-clinical-a (accessed on 28 June 2023).
- Akla, N.; Viallard, C.; Popovic, N.; Lora Gil, C.; Sapieha, P.; Larrivée, B. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability. Arterioscler. Thromb. Vasc. Biol. 2018, 38, 1821–1836. [Google Scholar] [CrossRef] [PubMed]
- Grigsby, J.; Allen, D.; Ferrigno, A.; Vellanki, S.; Pouw, C.; Hejny, W.; TC Tsin, A. Autocrine and Paracrine Secretion of Vascular Endothelial Growth Factor in the Pre-Hypoxic Diabetic Retina. Curr. Diabetes Rev. 2017, 13, 161–174. [Google Scholar] [CrossRef]
- Wu, M.Y.; Yiang, G.T.; Lai, T.T.; Li, C.J. The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy. Oxidative Med. Cell. Longev. 2018, 2018, 3420187. [Google Scholar] [CrossRef]
- Braunger, B.M.; Leimbeck, S.V.; Schlecht, A.; Volz, C.; Jägle, H.; Tamm, E.R. Deletion of Ocular Transforming Growth Factor β Signaling Mimics Essential Characteristics of Diabetic Retinopathy. Am. J. Pathol. 2015, 185, 1749–1768. [Google Scholar] [CrossRef]
- UpToDate. Diabetic Retinopathy: Prevention and Treatment. Available online: https://www.uptodate.com/contents/diabetic-retinopathy-prevention-and-treatment?search=diabetic%20retinopathy%20treatment&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 (accessed on 29 June 2023).
- Elmasry, K.; Habib, S.; Moustafa, M.; Al-Shabrawey, M. Bone Morphogenetic Proteins and Diabetic Retinopathy. Biomolecules 2021, 11, 593. [Google Scholar] [CrossRef]
- Munk, M.R.; Somfai, G.M.; De Smet, M.D.; Donati, G.; Menke, M.N.; Garweg, J.G.; Ceklic, L. The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers. Int. J. Mol. Sci. 2022, 23, 7585. [Google Scholar] [CrossRef]
- Dagher, Z.; Gerhardinger, C.; Vaz, J.; Goodridge, M.; Tecilazich, F.; Lorenzi, M. The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels. Am. J. Pathol. 2017, 187, 627–638. [Google Scholar] [CrossRef] [PubMed]
- Wheeler, S.E.; Lee, N.Y. Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy: TGF-β signaling in diabetic retinopathy. J. Cell. Physiol. 2017, 232, 486–489. [Google Scholar] [CrossRef] [PubMed]
- Massagué, J.; Sheppard, D. TGF-β signaling in health and disease. Cell 2023, 186, 4007–4037. [Google Scholar] [CrossRef]
- Huang, H. Pericyte-Endothelial Interactions in the Retinal Microvasculature. Int. J. Mol. Sci. 2020, 21, 7413. [Google Scholar] [CrossRef]
- Kim, K.S.; Park, J.M.; Kong, T.; Kim, C.; Bae, S.H.; Kim, H.W.; Moon, J. Retinal Angiogenesis Effects of TGF-β1 and Paracrine Factors Secreted from Human Placental Stem Cells in Response to a Pathological Environment. Cell Transplant. 2016, 25, 1145–1157. [Google Scholar] [CrossRef] [PubMed]
- Hachana, S.; Larrivée, B. TGF-β Superfamily Signaling in the Eye: Implications for Ocular Pathologies. Cells 2022, 11, 2336. [Google Scholar] [CrossRef] [PubMed]
- Nickel, J.; Ten Dijke, P.; Mueller, T.D. TGF-β; family co-receptor function and signaling. Acta Biochim. Biophys. Sin. 2018, 50, 12–36. [Google Scholar] [CrossRef] [PubMed]
- Liu, R.M.; Desai, L.P. Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis. Redox Biol. 2015, 6, 565–577. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.E. Non-Smad Signaling Pathways of the TGF-β Family. Cold Spring Harb. Perspect. Biol. 2016, 9, a022129. [Google Scholar] [CrossRef] [PubMed]
- Schoonderwoerd, M.J.A.; Goumans, M.J.T.H.; Hawinkels, L.J.A.C. Endoglin: Beyond the Endothelium. Biomolecules 2020, 10, 289. [Google Scholar] [CrossRef] [PubMed]
- Shu, D.Y.; Lovicu, F.J. Insights into Bone Morphogenetic Protein—(BMP-) Signaling in Ocular Lens Biology and Pathology. Cells 2021, 10, 2604. [Google Scholar] [CrossRef] [PubMed]
- Zorena, K.; Raczyńska, D.; Raczyńska, K. Biomarkers in Diabetic Retinopathy and the Therapeutic Implications. Mediat. Inflamm. 2013, 2013, 193604. [Google Scholar] [CrossRef]
- Bonfiglio, V.; Platania, C.B.M.; Lazzara, F.; Conti, F.; Pizzo, C.; Reibaldi, M.; Russo, A.; Fallico, M.; Ortisi, E.; Pignatelli, F.; et al. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy. Int. J. Mol. Sci. 2020, 21, 9558. [Google Scholar] [CrossRef]
- Liu, Y.; Paauwe, M.; Nixon, A.B.; Hawinkels, L.J.A.C. Endoglin Targeting: Lessons Learned and Questions That Remain. Int. J. Mol. Sci. 2020, 22, 147. [Google Scholar] [CrossRef]
- Desroches-Castan, A.; Tillet, E.; Bouvard, C.; Bailly, S. BMP9 and BMP10: Two close vascular quiescence partners that stand out. Dev. Dyn. 2021, 251, 158–177. [Google Scholar] [CrossRef]
- Beránek, M.; Kanková, K.; Benes, P.; Izakovicová-Hollá, L.; Znojil, V.; Hájek, D.; Vlková, E.; Vácha, J. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am. J. Med. Genet. 2002, 109, 278–283. [Google Scholar] [CrossRef]
- Wang, M.; Sheng, K.J.; Fang, J.C.; Zhao, H.; Lu, S.M.; Liu, Z.Y.; Chen, B.T. Redox signaling in diabetic retinopathy and opportunity for therapeutic intervention through natural products. Eur. J. Med. Chem. 2022, 244, 114829. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez, R.; Lowe, K.; Keniry, M.; Tsin, A. Involvement of TGFβ signaling pathway in oxidative stress and diabetic retinopathy. Arch. Clin. Exp. Ophthalmol. 2021, 3, 23–28. [Google Scholar] [PubMed]
- Khuu, L.A.; Tayyari, F.; Sivak, J.M.; Flanagan, J.G.; Singer, S.; Brent, M.H.; Huang, D.; Tan, O.; Hudson, C. Aqueous humour concentrations of TGF- β, PLGF and FGF-1 and total retinal blood flow in patients with early non-proliferative diabetic retinopathy. Acta Ophthalmol. 2017, 95, e206–e211. [Google Scholar] [CrossRef] [PubMed]
- McAuley, A.K.; Sanfilippo, P.G.; Hewitt, A.W.; Liang, H.; Lamoureux, E.; Wang, J.J.; Connell, P.P. Vitreous biomarkers in diabetic retinopathy: A systematic review and meta-analysis. J. Diabetes Its Complicat. 2014, 28, 419–425. [Google Scholar] [CrossRef]
- Liu, L.; Jiao, J.; Wang, Y.; Wu, J.; Huang, D.; Teng, W.; Chen, L. TGF-beta1 Gene Polymorphism in Association with Diabetic Retinopathy Susceptibility: A Systematic Review and Meta-Analysis. PLoS ONE 2014, 9, e94160. [Google Scholar] [CrossRef]
- Li, Q.; Pang, L.; Yang, W.; Liu, X.; Su, G.; Dong, Y. Long Non-Coding RNA of Myocardial Infarction Associated Transcript (LncRNA-MIAT) Promotes Diabetic Retinopathy by Upregulating Transforming Growth Factor-β1 (TGF-β1) Signaling. Med. Sci. Monit. 2018, 24, 9497–9503. [Google Scholar] [CrossRef]
- Shao, K.; Xi, L.; Cang, Z.; Chen, C.; Huang, S. Knockdown of NEAT1 exerts suppressive effects on diabetic retinopathy progression via inactivating TGF-β1 and VEGF signaling pathways. J. Cell. Physiol. 2020, 235, 9361–9369. [Google Scholar] [CrossRef]
- Saucedo, L.; Pfister, I.B.; Zandi, S.; Gerhardt, C.; Garweg, J.G. Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus. Mediat. Inflamm. 2021, 2021, 9811361. [Google Scholar] [CrossRef]
- Guo, J.; Zhou, P.; Pan, M.; Liu, Z.; An, G.; Han, J.; Dai, F.; Du, L.; Jin, X. Relationship between elevated microRNAs and growth factors levels in the vitreous of patients with proliferative diabetic retinopathy. J. Diabetes Complicat. 2021, 35, 108021. [Google Scholar] [CrossRef] [PubMed]
- Walshe, T.E.; Saint-Geniez, M.; Maharaj, A.S.R.; Sekiyama, E.; Maldonado, A.E.; D’Amore, P.A. TGF-β Is Required for Vascular Barrier Function, Endothelial Survival and Homeostasis of the Adult Microvasculature. PLoS ONE 2009, 4, e5149. [Google Scholar] [CrossRef] [PubMed]
- Pardali, E.; Goumans, M.J.; ten Dijke, P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol. 2010, 20, 556–567. [Google Scholar] [CrossRef] [PubMed]
- Yang, H.; Huang, Y.; Chen, X.; Liu, J.; Lu, Y.; Bu, L.; Xia, L.; Xiao, W.; Chen, M.; Nie, Q.; et al. The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-β2, elucidated by treatment with CTGFsiRNA. Acta Ophthalmol. 2010, 88, 652–659. [Google Scholar] [CrossRef] [PubMed]
- Xue, L.; Xiong, C.; Li, J.; Ren, Y.; Zhang, L.; Jiao, K.; Chen, C.; Ding, P. miR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway. Biosci. Rep. 2020, 40, BSR20201545. [Google Scholar] [CrossRef] [PubMed]
- Bian, Z.M.; Elner, S.G.; Elner, V.M. Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp. Eye Res. 2007, 84, 812–822. [Google Scholar] [CrossRef] [PubMed]
- Dai, Y.; Wu, Z.; Wang, F.; Zhang, Z.; Yu, M. Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous. BioMed. Res. Int. 2014, 2014, 486386. [Google Scholar] [CrossRef] [PubMed]
- Al-Shabrawey, M.; Hussein, K.; Wang, F.; Wan, M.; Elmasry, K.; Elsherbiny, N.; Saleh, H.; Yu, P.B.; Tawfik, A.; Ibrahim, A.S. Bone Morphogenetic Protein-2 Induces Non-Canonical Inflammatory and Oxidative Pathways in Human Retinal Endothelial Cells. Front. Immunol. 2021, 11, 568795. [Google Scholar] [CrossRef]
- Vogt, R.R.; Unda, R.; Yeh, L.C.C.; Vidro, E.K.; Lee, J.C.; Tsin, A.T. Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells. Cell. Biochem. 2006, 98, 1196–1202. [Google Scholar] [CrossRef] [PubMed]
- Nagineni, C.N.; Samuel, W.; Nagineni, S.; Pardhasaradhi, K.; Wiggert, B.; Detrick, B.; Hooks, J.J. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: Involvement of mitogen-activated protein kinases. J. Cell. Physiol. 2003, 197, 453–462. [Google Scholar] [CrossRef] [PubMed]
- Heinke, J.; Wehofsits, L.; Zhou, Q.; Zoeller, C.; Baar, K.M.; Helbing, T.; Laib, A.; Augustin, H.; Bode, C.; Patterson, C.; et al. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circ. Res. 2008, 103, 804–812. [Google Scholar] [CrossRef] [PubMed]
- Betts-Obregon, B.S.; Mondragon, A.A.; Mendiola, A.S.; LeBaron, R.G.; Asmis, R.; Zou, T.; Gonzalez-Fernandez, F.; Tsin, A.T. TGFβ induces BIGH3 expression and human retinal pericyte apoptosis: A novel pathway of diabetic retinopathy. Eye 2016, 30, 1639–1647. [Google Scholar] [CrossRef]
- Hong, S.; Lim, S.; Li, A.G.; Lee, C.; Lee, Y.S.; Lee, E.K.; Park, S.H.; Wang, X.J.; Kim, S.J. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat. Immunol. 2007, 8, 504–513. [Google Scholar] [CrossRef]
- Mondragon, A.A.; Betts-Obregon, B.S.; Moritz, R.J.; Parvathaneni, K.; Navarro, M.M.; Kim, H.S.; Lee, C.F.; LeBaron, R.G.; Asmis, R.; Tsin, A.T. BIGH3 protein and Macrophages in Retinal Endothelial Cell Apoptosis. Apoptosis 2014, 20, 29–37. [Google Scholar] [CrossRef]
- Bluestone, J.A.; Buckner, J.H.; Fitch, M.; Gitelman, S.E.; Gupta, S.; Hellerstein, M.K.; Herold, K.C.; Lares, A.; Lee, M.R.; Li, K.; et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci. Transl. Med. 2015, 7, 315ra189. [Google Scholar] [CrossRef]
- Zhang, S.; Gang, X.; Yang, S.; Cui, M.; Sun, L.; Li, Z.; Wang, G. The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases. Front. Immunol. 2021, 12, 678355. [Google Scholar] [CrossRef]
- Rudensky, A.Y. Regulatory T Cells and Foxp3. Immunol. Rev. 2011, 241, 260–268. [Google Scholar] [CrossRef]
- Yang, T.T.; Song, S.J.; Xue, H.B.; Shi, D.F.; Liu, C.M.; Liu, H. Regulatory T cells in the pathogenesis of type 2 diabetes mellitus retinopathy by miR-155. Eur. Rev. Med. Pharmacol. Sci. 2015, 19, 2010–2015. [Google Scholar]
- Wang, W.; Lo, A.C.Y. Diabetic Retinopathy: Pathophysiology and Treatments. Int. J. Mol. Sci. 2018, 19, 1816. [Google Scholar] [CrossRef] [PubMed]
- Chen, H.Y.; Ho, Y.J.; Chou, H.C.; Liao, E.C.; Tsai, Y.T.; Wei, Y.S.; Lin, L.H.; Lin, M.W.; Wang, Y.S.; Ko, M.L.; et al. The Role of Transforming Growth Factor-Beta in Retinal Ganglion Cells with Hyperglycemia and Oxidative Stress. Int. J. Mol. Sci. 2020, 21, 6482. [Google Scholar] [CrossRef] [PubMed]
- Chen, H.Y.; Ho, Y.J.; Chou, H.C.; Liao, E.C.; Tsai, Y.T.; Wei, Y.S.; Lin, L.H.; Lin, M.W.; Wang, Y.S.; Ko, M.L.; et al. TGF-β1 signaling protects retinal ganglion cells from oxidative stress via modulation of the HO-1/Nrf2 pathway. Chem. Biol. Interact. 2020, 331, 109249. [Google Scholar] [CrossRef] [PubMed]
- Khalid, M.; Petroianu, G.; Adem, A. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules 2022, 12, 542. [Google Scholar] [CrossRef] [PubMed]
- Vidro-Kotchan, E.; Yendluri, B.B.; Le-Thai, T.; Tsin, A. NBHA Reduces Acrolein-Induced Changes in ARPE-19 Cells: Possible Involvement of TGFβ. Curr. Eye Res. 2011, 36, 370–378. [Google Scholar] [CrossRef] [PubMed]
- Vidro, E.K.; Gee, S.; Unda, R.; Ma, J.; Tsin, A. Glucose and TGFβ2 Modulate the Viability of Cultured Human Retinal Pericytes and Their VEGF Release. Curr. Eye Res. 2008, 33, 984–993. [Google Scholar] [CrossRef] [PubMed]
- Sánchez-de-Diego, C.; Valer, J.A.; Pimenta-Lopes, C.; Rosa, J.L.; Ventura, F. Interplay between BMPs and Reactive Oxygen Species in Cell Signaling and Pathology. Biomolecules 2019, 9, 534. [Google Scholar] [CrossRef] [PubMed]
- Wu, L.; Li, J.; Zhao, F.; Xiang, Y. MiR-340-5p inhibits Müller cell activation and pro-inflammatory cytokine production by targeting BMP4 in experimental diabetic retinopathy. Cytokine 2021, 149, 155745. [Google Scholar] [CrossRef]
- Niu, Y.; Zhang, W.; Shi, J.; Liu, Y.; Zhang, H.; Lin, N.; Li, X.; Qin, L.; Yang, Z.; Su, Q. The Relationship Between Circulating Growth Differentiation Factor 15 Levels and Diabetic Retinopathy in Patients With Type 2 Diabetes. Front. Endocrinol. 2021, 12, 627395. [Google Scholar] [CrossRef]
- Chung, J.O.; Park, S.Y.; Cho, D.H.; Chung, D.J.; Chung, M.Y. Relationship between plasma growth differentiation factor-15 levels and diabetic retinopathy in individuals with type 2 diabetes. Sci. Rep. 2020, 10, 20568. [Google Scholar] [CrossRef]
- Whitson, R.J.; Lucia, M.S.; Lambert, J.R. Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2). J. Cell. Biochem. 2012, 114, 1424–1433. [Google Scholar] [CrossRef]
- Wong, T.Y.; Cheung, C.M.G.; Larsen, M.; Sharma, S.; Simó, R. Diabetic retinopathy. Nat. Rev. Dis. Primers 2016, 2, 16012. [Google Scholar] [CrossRef]
- Zhang, M.; Zhou, M.; Cai, X.; Zhou, Y.; Jiang, X.; Luo, Y.; Hu, Y.; Qiu, R.; Wu, Y.; Zhang, Y.; et al. VEGF promotes diabetic retinopathy by upregulating the PKC/ET/NF-κB/ICAM-1 signaling pathway. Eur. J. Histochem. 2022, 66, 3522. [Google Scholar] [CrossRef]
- Cho, C.H.; Roh, K.H.; Lim, N.Y.; Park, S.J.; Park, S.; Kim, H.W. Role of the JAK/STAT pathway in a streptozotocin-induced diabetic retinopathy mouse model. Graefes Arch. Clin. Exp. Ophthalmol. 2022, 260, 3553–3563. [Google Scholar] [CrossRef]
- Kim, J.; Wu, H.H.; Lander, A.D.; Lyons, K.M.; Matzuk, M.M.; Calof, A.L. GDF11 Controls the Timing of Progenitor Cell Competence in Developing Retina. Science 2005, 308, 1927–1930. [Google Scholar] [CrossRef]
- Zhang, J.; Li, Y.; Li, H.; Zhu, B.; Wang, L.; Guo, B.; Xiang, L.; Dong, J.; Liu, M.; Xiang, G. GDF11 Improves Angiogenic Function of EPCs in Diabetic Limb Ischemia. Diabetes 2018, 67, 2084–2095. [Google Scholar] [CrossRef]
- Mei, W.; Zhu, B.; Shu, Y.; Liang, Y.; Lin, M.; He, M.; Luo, H.; Ye, J. GDF11 protects against glucotoxicity-induced mice retinal microvascular endothelial cell dysfunction and diabetic retinopathy disease. Mol. Cell. Endocrinol. 2021, 537, 111422. [Google Scholar] [CrossRef] [PubMed]
- Curtis, T.M.; Hamilton, R.; Yong, P.H.; McVicar, C.M.; Berner, A.; Pringle, R.; Uchida, K.; Nagai, R.; Brockbank, S.; Stitt, A.W. Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia 2010, 54, 690–698. [Google Scholar] [CrossRef] [PubMed]
- Grigsby, J.; Betts, B.; Vidro-Kotchan, E.; Culbert, R.; Tsin, A. A Possible Role of Acrolein in Diabetic Retinopathy: Involvement of a VEGF/TGFβ Signaling Pathway of the Retinal Pigment Epithelium in Hyperglycemia. Curr. Eye Res. 2012, 37, 1045–1053. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Callan, A.; Jha, S.; Valdez, L.; Baldado, L.; Tsin, A. TGF-β Signaling Pathways in the Development of Diabetic Retinopathy. Int. J. Mol. Sci. 2024, 25, 3052. https://doi.org/10.3390/ijms25053052
Callan A, Jha S, Valdez L, Baldado L, Tsin A. TGF-β Signaling Pathways in the Development of Diabetic Retinopathy. International Journal of Molecular Sciences. 2024; 25(5):3052. https://doi.org/10.3390/ijms25053052
Chicago/Turabian StyleCallan, Andrew, Sonal Jha, Laura Valdez, Lois Baldado, and Andrew Tsin. 2024. "TGF-β Signaling Pathways in the Development of Diabetic Retinopathy" International Journal of Molecular Sciences 25, no. 5: 3052. https://doi.org/10.3390/ijms25053052